Members of the National Association of Corporate Directors and others in the Research Triangle area and Eastern North Carolina who exhibit high potential for public or private company board service are eligible for money to help fund NACD.DC credentials.
Read More
RESEARCH TRIANGLE PARK – How odd that the largest venture capital event in North Carolina took place Wednesday and Thursday at the GSK campus in RTP just days after the death of Robert “Bob” Ingram who led the merger that ultimately turned Burroughs-Wellcome/Glaxo Wellcome into Glaxo Smith Kline. But...
Read More
This is the first in a series of interviews from WRAL TechWire featuring “Legends – The men and women who helped create and build North Carolina’s technology and life science ecosystem.” These leaders will join Jim Goodnight, Monica Doss, Dennis Daugherty, Charles Hamner and Venessa Harrison as members of WRAL TechWire’s virtual Hall of Fame, which named its first members in 2017.
Read More
Six months ago Thursday, 111 Duke St. in Durham was a pristine brick building that didn’t really provide many clues about the luxury hardware contained inside. For Robert “Bob” Ingram, collecting the cars is more than a hobby, it’s a family passion. He talks about the explosion and the collections in an interview with WRAL’s Debra Morgan.
Read MoreBob Ingram, chairman of Novan, a Morrisville-based company that specializes in nitric-oxide based therapies for skin conditions, has purchased $142,000 in company stock,
Read MoreThe chief commercial officer of Novan Inc., a pharmaceutical development company, abruptly resigned last week, according to a filing with the Securities and Exchange Commission.
Read MoreDurham-based BioCryst Pharmaceuticals has signed a definitive merger agreement with Idera Pharmaceuticals. Biocryst board chair Bob Ingram will lead the board of the merged firm.
Read More
